Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1 2

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Non-Small-Cell Lung 190Lung Neoplasms 67Ovarian Neoplasms 64Breast Neoplasms 38Fallopian Tube Neoplasms 33Small Cell Lung Carcinoma 31Parkinson Disease 4, Autosomal Dominant Lewy Body 27Carcinoma, Ovarian Epithelial 24Uterine Cervical Neoplasms 22Triple Negative Breast Neoplasms 22Squamous Cell Carcinoma of Head and Neck 19Neuroblastoma 17Carcinoma 17Adenocarcinoma of Lung 17Neoplasm Metastasis 15Endometrial Neoplasms 14Neoplasms 12Head and Neck Neoplasms 11Recurrence 8Peritoneal Neoplasms 8Carcinoma, Transitional Cell 8Esophageal Neoplasms 7Central Nervous System Neoplasms 7Brenner Tumor 7Urinary Bladder Neoplasms 6Lung Diseases 6Adenocarcinoma, Bronchiolo-Alveolar 6Thoracic Neoplasms 5Testicular Neoplasms 5Respiratory Tract Neoplasms 5

Interventions

Radiotherapy 5Mitomycin 5Fluorouracil 5Watchful Waiting 3Paclitaxel 3Nivolumab 3Cisplatin 3Vaccines 2Radiation 2Observation 2Light Coagulation 2Carboplatin 2Capecitabine 2pembrolizumab 1nanocis 1cemiplimab 1atezolizumab 1X-Rays 1Vaccines, Synthetic 1Technetium-99 1Taxes 1Specimen Handling 1Sigmoidoscopy 1Proctoscopy 1Phantoms, Imaging 1Papillomavirus Vaccines 1Octreotide 1Neoadjuvant Therapy 1Mitomycins 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Anus Neoplasms × Carboplatin × Clear all
NCT04444921 2026-05-29

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

National Cancer Institute (NCI)

Phase 3 Active not recruiting
205 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT04472429 2025-11-03

Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

Incyte Corporation

Phase 3 Completed
308 enrolled 17 charts 1 FDA
Gastrointestinal

Anus Neoplasms, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡